BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35707002)

  • 21. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
    Pistore C; Giannoni E; Colangelo T; Rizzo F; Magnani E; Muccillo L; Giurato G; Mancini M; Rizzo S; Riccardi M; Sahnane N; Del Vescovo V; Kishore K; Mandruzzato M; Macchi F; Pelizzola M; Denti MA; Furlan D; Weisz A; Colantuoni V; Chiarugi P; Bonapace IM
    Oncogene; 2017 Oct; 36(40):5551-5566. PubMed ID: 28581528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.
    Bowe RA; Cox OT; Ayllón V; Tresse E; Healy NC; Edmunds SJ; Huigsloot M; O'Connor R
    Mol Biol Cell; 2014 Jan; 25(1):184-95. PubMed ID: 24196835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
    Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma.
    Wen CY; Tsui KH; Chang CH; Chiu YH; Lin SA; Chu CY; Li CJ
    J Oncol; 2022; 2022():9854788. PubMed ID: 35132321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
    Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
    Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
    [No Abstract]   [Full Text] [Related]  

  • 26. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
    Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
    Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J
    Front Immunol; 2022; 13():754645. PubMed ID: 35281030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the PDLIM family in acute myeloid leukemia.
    Cui L; Cheng Z; Hu K; Pang Y; Liu Y; Qian T; Quan L; Dai Y; Pang Y; Ye X; Shi J; Fu L
    Am J Transl Res; 2019; 11(9):6124-6131. PubMed ID: 31632581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
    Shi H; Ji Y; Li W; Zhong Y; Ming Z
    Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes.
    Zheng J; Dong H; Zhang T; Ning J; Xu Y; Cai C
    Front Genet; 2022; 13():865052. PubMed ID: 35559024
    [No Abstract]   [Full Text] [Related]  

  • 31. LTF Regulates the Immune Microenvironment of Prostate Cancer Through JAK/STAT3 Pathway.
    Zhao Q; Cheng Y; Xiong Y
    Front Oncol; 2021; 11():692117. PubMed ID: 34868909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC.
    Mahmoudian RA; Mozhgani S; Abbaszadegan MR; Mokhlessi L; Montazer M; Gholamin M
    J Mol Histol; 2021 Jun; 52(3):597-609. PubMed ID: 33884540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance.
    Sun F; Li L; Yan P; Zhou J; Shapiro SD; Xiao G; Qu Z
    Nat Commun; 2019 Nov; 10(1):5324. PubMed ID: 31757943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
    Xin W; Zhao C; Jiang L; Pei D; Zhao L; Zhang C
    Pathol Oncol Res; 2021; 27():585192. PubMed ID: 34257533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kruppel like factor 10 up-regulates PDZ and LIM domain containing protein 2 via nuclear factor kappa-B pathway to inhibit proliferation and inflammatory of fibroblastoid synovial cell in rheumatoid arthritis.
    Wang S; Zha X; Ruan S; Yao S; Zhang X
    Bioengineered; 2022 Jan; 13(1):1779-1790. PubMed ID: 34713769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer.
    Li H; Wang C; Lan L; Behrens A; Tomaschko M; Ruiz J; Su Q; Zhao G; Yuan C; Xiao X; Li B; Yan L; Wu W; Li W; Chen J; He Y; Zhang C
    Aging (Albany NY); 2021 Feb; 13(4):5197-5225. PubMed ID: 33535187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling.
    Zhao L; Yu C; Zhou S; Lau WB; Lau B; Luo Z; Lin Q; Yang H; Xuan Y; Yi T; Zhao X; Wei Y
    Oncotarget; 2016 Jan; 7(2):1408-20. PubMed ID: 26593252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.
    Paniagua-Herranz L; Moreno I; Nieto-Jiménez C; Garcia-Lorenzo E; Díaz-Tejeiro C; Sanvicente A; Doger B; Pedregal M; Ramón J; Bartolomé J; Manzano A; Gyorffy B; Gutierrez-Uzquiza Á; Pérez Segura P; Calvo E; Moreno V; Ocana A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.